Compare Sun Pharma with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA NATCO PHARMA SUN PHARMA/
NATCO PHARMA
 
P/E (TTM) x 32.7 41.2 79.5% View Chart
P/BV x 4.3 4.0 108.8% View Chart
Dividend Yield % 0.9 0.6 152.6%  

Financials

 SUN PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    SUN PHARMA
Mar-21
NATCO PHARMA
Mar-21
SUN PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs654995 65.7%   
Low Rs339492 68.8%   
Sales per share (Unadj.) Rs139.6112.5 124.1%  
Earnings per share (Unadj.) Rs9.524.3 39.2%  
Cash flow per share (Unadj.) Rs18.230.7 59.3%  
Dividends per share (Unadj.) Rs7.505.25 142.9%  
Avg Dividend yield %1.50.7 214.1%  
Book value per share (Unadj.) Rs193.6225.1 86.0%  
Shares outstanding (eoy) m2,399.34182.34 1,315.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.66.6 53.8%   
Avg P/E ratio x52.130.6 170.0%  
P/CF ratio (eoy) x27.324.2 112.5%  
Price / Book Value ratio x2.63.3 77.6%  
Dividend payout %78.821.6 364.0%   
Avg Mkt Cap Rs m1,190,430135,564 878.1%   
No. of employees `000NANA-   
Total wages/salary Rs m68,6224,149 1,653.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m334,98120,521 1,632.4%  
Other income Rs m8,5921,036 829.3%   
Total revenues Rs m343,57321,557 1,593.8%   
Gross profit Rs m41,6166,062 686.5%  
Depreciation Rs m20,8001,169 1,779.3%   
Interest Rs m1,414133 1,063.4%   
Profit before tax Rs m27,9945,796 483.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1471,372 375.1%   
Profit after tax Rs m22,8474,424 516.4%  
Gross profit margin %12.429.5 42.1%  
Effective tax rate %18.423.7 77.7%   
Net profit margin %6.821.6 31.6%  
BALANCE SHEET DATA
Current assets Rs m304,42123,373 1,302.4%   
Current liabilities Rs m161,4565,256 3,071.8%   
Net working cap to sales %42.788.3 48.3%  
Current ratio x1.94.4 42.4%  
Inventory Days Days14963 237.8%  
Debtors Days Days9973 134.4%  
Net fixed assets Rs m336,68224,546 1,371.6%   
Share capital Rs m2,399365 657.3%   
"Free" reserves Rs m462,22940,676 1,136.4%   
Net worth Rs m464,62841,041 1,132.1%   
Long term debt Rs m8,9819 99,792.2%   
Total assets Rs m641,10347,919 1,337.9%  
Interest coverage x20.844.6 46.6%   
Debt to equity ratio x00 8,814.7%  
Sales to assets ratio x0.50.4 122.0%   
Return on assets %3.89.5 39.8%  
Return on equity %4.910.8 45.6%  
Return on capital %6.214.4 43.0%  
Exports to sales %00-   
Imports to sales %010.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA2,231 0.0%   
Fx inflow Rs m84,49311,194 754.8%   
Fx outflow Rs m30,3342,231 1,359.6%   
Net fx Rs m54,1598,963 604.3%   
CASH FLOW
From Operations Rs m61,7042,988 2,065.1%  
From Investments Rs m5,362-1,033 -519.1%  
From Financial Activity Rs m-59,805-1,857 3,220.5%  
Net Cashflow Rs m5,96460 9,940.3%  

Share Holding

Indian Promoters % 54.7 48.9 111.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 32.8 30.3 108.2%  
FIIs % 12.7 12.5 101.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.3 51.1 88.6%  
Shareholders   653,359 88,439 738.8%  
Pledged promoter(s) holding % 6.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   SANDU PHARMA  RELISH PHARMA  KREBS BIOCHEMICALS  UNJHA FORMUL  WANBURY  



Today's Market

Sensex Zooms 600 Points, Dow Futures Up by 326 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 620 points, up 1%, at 61,926 levels.

Related Views on News

NATCO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 18, 2021 | Updated on Oct 18, 2021

Here's an analysis of the annual report of NATCO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NATCO PHARMA. Also includes updates on the valuation of NATCO PHARMA.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Oct 18, 2021 03:36 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - AARTI DRUGS COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS